Join
Live feed
·
PRReleasevia Quantisnow
Aethlon Medical Inc. logo

Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis

ByQuantisnow·Wall Street's wire, on your screen.
AEMD· Aethlon Medical Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AEMD (Aethlon Medical Inc.) and more on Quantisnow.